A COMBINATION THERAPY STRATEGY TO REVERSE ANTI-PD-1 THERAPY RESISTANCE IN METASTATIC OVARIAN CANCER PATIENTS

$354,835FY2020Defense Health AgencyDOD

Georgetown University, Washington DC

Investigators